Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN)

CUSIP: 59045L106

Q4 2020 13F Holders as of 31 Dec 2020

Holder snapshot 7 signals
Share change
-265,069
Put/Call ratio
39%
SEC-reported price per share
$26.61
Number of holders
147
Value change
+$51,864,511
Number of buys
81
Open additional details 1 more signal available
Number of sells
59
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
4,992,318

Security key

59045L106

Report period

Q4 2020

Institutions

147

Top holders

10

Ownership snapshot

Top reported holders of MRSN - Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
30 Sep 2020
13F Lead comparable stake: 145% Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. leads the comparable SEC ownership view at 145%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock Finance, Inc. 145%
Avoro Capital Advisors LLC 136%
NEA Management Company, LLC 119%
WELLINGTON MANAGEMENT GROUP LLP 76%
Consonance Capital Management LP 69%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
145%
$135,031,000
7,252,006 shares
30 Sep 2020
Avoro Capital Advisors LLC
13F
Company
13F
136%
$126,616,000
6,800,000 shares
30 Sep 2020
NEA Management Company, LLC
13F
Company
13F
119%
$110,966,000
5,959,520 shares
30 Sep 2020
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
76%
$70,585,000
3,790,832 shares
30 Sep 2020
Consonance Capital Management LP
13F
Company
13F
69%
$64,577,000
3,468,171 shares
30 Sep 2020
Bain Capital Life Sciences Investors, LLC
13F
Company
13F
69%
$64,158,000
3,445,667 shares
30 Sep 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
147
Shares
68,137,745
Rows available
147
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2020 vs Q4 2025 Across Filers

Q4 2025 holders
3
Q4 2020 holders
147
Holder diff
144
Investor Q4 2025 Shares Q4 2020 Shares Share Diff Share Chg % Q4 2025 value Q4 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .